Dr. Christoph Borchers
Dr. Christoph Borchers is recognized as a pioneer and leading figure in the development of mass spectrometry-based methods for protein quantification using Multiple Reaction Monitoring (MRM) and structural proteomics. He has published more than 325 peer-reviewed papers and is the founder and director of the McGill-Lady Davis Institute Integrated Proteomics Program at the Jewish General Hospital, McGill University, where he is currently a Full Professor in the Department of Oncology.
Dr. Borchers received his PhD degree from the University of Konstanz, Germany in 1996. After his post-doctoral training at the NIEHS/NIH/RTP, NC he became the director of the UNC-Duke Proteomics Facility and held a faculty position at the UNC Medical School in Chapel Hill, NC (2001-2006). From 2006 to 2019, he was a Professor in the Department of Biochemistry & Microbiology, and Director of the Genome BC Proteomics Centre at the University of Victoria, BC, Canada, where he held the Rix BC Leadership Chair in Biomedical and Environmental Proteomics.
Dr. Borchers was also involved in promoting proteomics research and education through his involvement with HUPO (International Council Member), the British Columbia Proteomics Network (Executive Committee Member, past Scientific Director) and the Canadian National Proteomics Network (Member, past VP External and Chair of the Board of Directors). He is also a Fellow of the Canadian Academy of Health Sciences.
Dr. René Zahedi
Dr. René Zahedi is the Associate Director of the Segal Cancer Proteomics Centre in Montreal. He received his PhD from the University of Wuerzburg/Germany in 2008 (the phosphoproteome of human platelets). He has been a junior-(2010-14) and permanent senior-PI (2014-17) at the Leibniz-Institute for Analytical Sciences (ISAS), where he developed methods for the analysis of proteins and their post-translational modifications (PTMs) in clinical samples, using protein-MS. He has published >140 peer-reviewed manuscripts, including pioneering work on protein- and PTM-changes in human platelets, and their roles in cardiovascular disease and platelet disorders.
Dr. Zahedi was head of the Bioanalytics Study Group of the German Society for Biochemistry and Molecular Biology (GBM) from 2010-2017 and a member of the Education Committee of the European Proteomics Association (EuPA) from 2015-2017. He was a lecturer at the TU Dortmund and an invited instructor for international meetings/workshops (e.g. EMBL-EBI Proteomics Bioinformatics Advanced Courses 2014,2015,2016). He has (co-)supervised >20 PhD students, some of which having received prestigious awards under his direct supervision.